Top

BY Jim Allison, Ph.D.

For a long time, immunotherapy was considered nonsense by many people in mainstream cancer medicine. It had been tried for years, starting with a German scientist named Paul Ehrlich in 1906. There’d been a lot of other attempts since then, particularly in the 1960s and 1980s, but none of them really worked.

Unfortunately, there was a lot of hype around those efforts each time. So, when they didn’t pan out, the field as a whole...

Nobel Prize-winning immunotherapy researcher Jim Allison, Ph.D.

BY Constance Blanchard

Rare. Unusual. Anomaly. All of these words are synonymous with being a long-term glioblastoma survivor. All statistical data suggests that...

BY Meagan Raeke

A new study has revived hope for the role of immunotherapy in treating glioblastoma, the most aggressive and deadly form of brain cancer in...

BY Shiao-Pei Weathers, M.D.

Glioblastoma is the most common and aggressive primary brain tumor in adults. Although it’s considered a rare cancer, with about 12,000 new diagnoses each year, it’s gained increased visibility recently with the diagnoses of a few high-profile people. 

As a neuro-oncologist and the clinical medical director of MD Anderson’s Brain and Spine Center, part of my job is to make sure glioblastoma patients and their families understand...

Glioblastoma expert Shiao-Pei Weathers, M.D.

BY Brooke Boudoin

I was 12 when my 19-year-old brother, Brandon, was diagnosed with glioblastoma, the most common and aggressive form of brain cancer. I remember...

BY Meagan Raeke

Imagine being able to talk to your doctors during brain tumor surgery without pain and give them immediate feedback while they operate...

BY Andrew Futreal, Ph.D.

 

While its name was inspired by President John F. Kennedy’s ambitious goal to put a man on the moon, the Moon Shots Program...

BY MD Anderson Staff

Bratton Fennell, 53, is one of the top-ranked distance runners for his age group in the Carolinas. During his brain tumor treatment, it turned...

BY Meagan Raeke

When Suzanne Stone completed her first half-marathon in February, the achievement was extra sweet: she’d managed to finish the long-distance...

BY Cammie Shaddock

My brain tumor diagnosis came suddenly. I had no pain, headaches or any kind of warning. On Oct. 3, 2016, I had difficulty conveying my thoughts...